Mario Gabelli Astrazeneca PLC Transaction History

Gamco Investors, Inc. Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $13,823 - $17,962	255 Added 4.2%	6,320 $428,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $222,949 - $570,828	-4,205 Reduced 40.94%	6,065 $375,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $1,718 - $2,063	-29 Reduced 0.28%	10,270 $679,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $16,660 - $20,068	299 Added 2.99%	10,299 $683,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $245,791 - $290,426	-4,550 Reduced 31.27%	10,000 $583,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $808,398 - $884,494	14,550 New	14,550 $874,000

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.